Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice

American Journal of Alzheimer's Disease and other Dementias

Volumn 19, Issue 3, 2004, Pages 153-160

  Capsoni, Simona ^a   Giannotta, Sabina ^b   Stebel, Marco ^a,c   Garcia, Addys Ancheta ^a   De Rosa, Roberta ^a   Villetti, Gino ^d   Imbimbo, Bruno Pietro ^d   Pietra, Claudio ^d   Cattaneo, Antonino ^b,d  

^a Lay Line Genomics SpA   (Italy)

^b SISSA   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Acetylcholinesterase inhibitors; Alzheimer's disease; Donepezil; Ganstigmine; Therapeutic agents

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GANSTIGMINE; NERVE GROWTH FACTOR ANTIBODY; PLACEBO; SCOPOLAMINE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 2942535892     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/153331750401900303     Document Type: Article

References (18)

1. Selkoe DJ: Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev. 2001; 81(2): 741-766.
2. Giacobini E: Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry. 2003; 18(Suppl 1): S1-S5.
3. Tariot PN, Federoff HJ: Current treatment for Alzheimer disease and future prospects. Alzheimer Dis Assoc Disord. 2003; 17(Suppl 4): S105-S113.
4. Pietra C, Villetti G, Bolzoni PT, et al.: Cholinesterase inhibitory activity of new geneserine derivatives. Alzheimer Dis Assoc Disord. 1999: 689-696.
5. Trabace L, Cassano T, Steardo L, et al.: Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease. J Pharmacol Exp Ther 2000; 294(1): 187-94.
6. Windisch M, Hutter-Paier B, Jerkovic L, et al.: The protective effect of ganstigmine against amyloid beta 25-35 neurotoxicity on chicken cortical neurons is independent from the cholinesterase inhibition. Neurosci Lett. 2003; 341(3): 181-4.
7. Capsoni S, Giannotta S, Cattaneo A: Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies. Mol Cell Neurosci. 2002; 21(1): 15-28.
8. Capsoni S, Giannotta S, Cattaneo A: Early events of alzheimer like neurodegeneration in anti-nerve growth factor transgenic mice. Brain Aging. 2002; 2:24-43.
9. Capsoni S, Ugolini G, Comparini A, et al.: Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci. 2000; 97(12): 6826-6831
10. Ruberti F, Capsoni S, Comparini A, et al.: Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci. 2000; 20(7): 2589-2601.
11. Pesavento E, Capsoni S, Domenici L, et al.: Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of antinerve-growth-factor mice. Eur J Neurosci. 2002; 15(6): 1030-1036.
12. Franklin KBJ, Paxinos GT: The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press, 1997.
13. Russo C, Salis S, Dolcini V, et al.: Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Neurobiol Dis. 2001; 8(1): 173-180.
14. Capsoni S, Giannotta S, Cattaneo A: Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Natl Acad Sci. 2002; 99(19): 12432-12437.
15. Ridley RM, Baker, HF: A critical evaluation of monkey models of amnesia and dementia. Brain Res Rev. 1991; 16: 15-37.
16. Beatty W, Winn P, Adams R, et al.: Preserved cognitive skills in dementia of the Alzheimer type. Arch Neurol. 1994; 51: 1040-1046.
17. Ennaceur A, Delacour J: A new one-trial test for neurobiological studies of memory in rats: I: Behavioral data. J Behav Brain Res. 1988; 31: 47-59.
18. Giacobini E: Cholinesterase inhibitors stabilize Alzheimer disease. Neurochem Res. 2000; 25(9-10): 1185-1190.